These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 36477579)

  • 1. Prevalence and Effects of High-Intensity Statins for Japanese Patients Presenting With Acute Coronary Syndrome　- A Post Hoc Secondary Analysis of STOPDAPT-2 ACS.
    Watanabe H; Morimoto T; Yamamoto K; Obayashi Y; Natsuaki M; Yamaji K; Ogita M; Suwa S; Isawa T; Domei T; Ando K; Tatsushima S; Watanabe H; Oya M; Kadota K; Tokuyama H; Tada T; Sakamoto H; Mori H; Suzuki H; Nishikura T; Wakabayashi K; Kimura T;
    Circ J; 2023 Apr; 87(5):657-668. PubMed ID: 36477579
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aspirin-free strategy for percutaneous coronary intervention in acute coronary syndrome based on the subtypes of acute coronary syndrome and high bleeding risk: the STOPDAPT-3 trial.
    Obayashi Y; Natsuaki M; Watanabe H; Morimoto T; Yamamoto K; Nishikawa R; Ando K; Suwa S; Isawa T; Takenaka H; Ishikawa T; Tokuyama H; Sakamoto H; Fujita T; Nanasato M; Okayama H; Nishikura T; Kirigaya H; Nishida K; Ono K; Kimura T;
    Eur Heart J Cardiovasc Pharmacother; 2024 Aug; 10(5):374-390. PubMed ID: 38285607
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Concomitant administration of clopidogrel with statins or calcium-channel blockers: insights from the TRITON-TIMI 38 (trial to assess improvement in therapeutic outcomes by optimizing platelet inhibition with prasugrel-thrombolysis in myocardial infarction 38).
    Ojeifo O; Wiviott SD; Antman EM; Murphy SA; Udell JA; Bates ER; Mega JL; Sabatine MS; O'Donoghue ML
    JACC Cardiovasc Interv; 2013 Dec; 6(12):1275-81. PubMed ID: 24239201
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clopidogrel Monotherapy After 1-Month Dual Antiplatelet Therapy in Percutaneous Coronary Intervention: From the STOPDAPT-2 Total Cohort.
    Obayashi Y; Watanabe H; Morimoto T; Yamamoto K; Natsuaki M; Domei T; Yamaji K; Suwa S; Isawa T; Watanabe H; Yoshida R; Sakamoto H; Akao M; Hata Y; Morishima I; Tokuyama H; Yagi M; Suzuki H; Wakabayashi K; Suematsu N; Inada T; Tamura T; Okayama H; Abe M; Kawai K; Nakao K; Ando K; Tanabe K; Ikari Y; Morino Y; Kadota K; Furukawa Y; Nakagawa Y; Kimura T;
    Circ Cardiovasc Interv; 2022 Aug; 15(8):e012004. PubMed ID: 35912647
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clopidogrel Monotherapy After 1-Month Dual Antiplatelet Therapy in Patients With Diabetes Undergoing Percutaneous Coronary Intervention.
    Yamamoto K; Watanabe H; Morimoto T; Obayashi Y; Natsuaki M; Yamaji K; Domei T; Ogita M; Ohya M; Tatsushima S; Suzuki H; Tada T; Ishii M; Nikaido A; Watanabe N; Fujii S; Mori H; Nishikura T; Suematsu N; Hayashi F; Komiyama K; Shigematsu T; Isawa T; Suwa S; Ando K; Kimura T;
    JACC Cardiovasc Interv; 2023 Jan; 16(1):19-31. PubMed ID: 36599584
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of High-Intensity Atorvastatin for Asian Patients Undergoing Percutaneous Coronary Intervention.
    Liu Z; Joerg H; Hao H; Xu J; Hu S; Li B; Sang C; Xia J; Chu Y; Xu D
    Ann Pharmacother; 2016 Sep; 50(9):725-33. PubMed ID: 27307415
    [TBL] [Abstract][Full Text] [Related]  

  • 7. One-year clinical outcomes of patients with versus without acute coronary syndrome with 3-month duration of dual antiplatelet therapy after everolimus-eluting stent implantation.
    Natsuaki M; Morimoto T; Yamamoto E; Watanabe H; Furukawa Y; Abe M; Nakao K; Ishikawa T; Kawai K; Yunoki K; Shimizu S; Akao M; Miki S; Yamamoto M; Okada H; Hoshino K; Kadota K; Morino Y; Hanaoka KI; Tanabe K; Kozuma K; Kimura T;
    PLoS One; 2020; 15(3):e0227612. PubMed ID: 32210433
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of statin therapy on patients with coronary heart disease and aortic aneurysm or dissection.
    Tazaki J; Morimoto T; Sakata R; Okabayashi H; Yamazaki F; Nishiwaki N; Mitsudo K; Kimura T;
    J Vasc Surg; 2014 Sep; 60(3):604-12.e2. PubMed ID: 24797553
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The residual risk of inflammation and remnant cholesterol in acute coronary syndrome patients on statin treatment undergoing percutaneous coronary intervention.
    Liao J; Qiu M; Su X; Qi Z; Xu Y; Liu H; Xu K; Wang X; Li J; Li Y; Han Y
    Lipids Health Dis; 2024 Jun; 23(1):172. PubMed ID: 38849939
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Post-procedural Anticoagulation With Unfractionated Heparin in Acute Coronary Syndrome: Insight from the STOPDAPT-3 Trial.
    Watanabe H; Natsuaki M; Morimoto T; Yamamoto K; Obayashi Y; Nishikawa R; Hamatani Y; Ando K; Domei T; Suwa S; Ogita M; Isawa T; Takenaka H; Yamamoto T; Ishikawa T; Hisauchi I; Wakabayashi K; Onishi Y; Hibi K; Kawai K; Yoshida R; Suzuki H; Nakazawa G; Kusuyama T; Morishima I; Ono K; Kimura T;
    Am J Cardiol; 2024 Sep; 226():83-96. PubMed ID: 38972535
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Usefulness of Elevated Levels of Growth Differentiation Factor-15 to Classify Patients With Acute Coronary Syndrome Having Percutaneous Coronary Intervention Who Would Benefit from High-Dose Statin Therapy.
    Tentzeris I; Farhan S; Freynhofer MK; Rohla M; Jarai R; Vogel B; Baumgartner-Parzer S; Nürnberg M; Geppert A; Wessely E; Wojta J; Huber K; Kautzky-Willer A
    Am J Cardiol; 2017 Sep; 120(5):747-752. PubMed ID: 28734463
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of diabetes on clinical outcome among elderly patients with acute coronary syndrome treated with percutaneous coronary intervention: insights from the ELDERLY ACS 2 trial.
    De Luca G; Verdoia M; Savonitto S; Piatti L; Grosseto D; Morici N; Bossi I; Sganzerla P; Tortorella G; Cacucci M; Murena E; Toso A; Bongioanni S; Ravera A; Corrada E; Mariani M; Di Ascenzo L; Petronio AS; Cavallini C; Vitrella G; Antonicelli R; Rogacka R; De Servi S;
    J Cardiovasc Med (Hagerstown); 2020 Jun; 21(6):453-459. PubMed ID: 32355067
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Harmonizing Optimal Strategy for Treatment of coronary artery diseases--comparison of REDUCtion of prasugrEl dose or POLYmer TECHnology in ACS patients (HOST-REDUCE-POLYTECH-ACS RCT): study protocol for a randomized controlled trial.
    Lee JM; Jung JH; Park KW; Shin ES; Oh SK; Bae JW; Rhew JY; Lee N; Kim DB; Kim U; Han JK; Lee SE; Yang HM; Kang HJ; Koo BK; Kim S; Cho YK; Shin WY; Lim YH; Rha SW; Kim SY; Lee SY; Kim YD; Chae IH; Cha KS; Kim HS
    Trials; 2015 Sep; 16():409. PubMed ID: 26374625
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Statins for acute coronary syndrome.
    Vale N; Nordmann AJ; Schwartz GG; de Lemos J; Colivicchi F; den Hartog F; Ostadal P; Macin SM; Liem AH; Mills EJ; Bhatnagar N; Bucher HC; Briel M
    Cochrane Database Syst Rev; 2014 Sep; 2014(9):CD006870. PubMed ID: 25178118
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-Intensity Versus Non-High-Intensity Statins in Patients Achieving Low-Density Lipoprotein Cholesterol Goal After Percutaneous Coronary Intervention.
    Kim J; Park KT; Jang MJ; Park TK; Lee JM; Yang JH; Song YB; Choi SH; Gwon HC; Lee SH; Hong KP; Hahn JY
    J Am Heart Assoc; 2018 Nov; 7(21):e009517. PubMed ID: 30376751
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and Safety of Cangrelor in Preventing Periprocedural Complications in Patients With Stable Angina and Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention: The CHAMPION PHOENIX Trial.
    Abtan J; Steg PG; Stone GW; Mahaffey KW; Gibson CM; Hamm CW; Price MJ; Abnousi F; Prats J; Deliargyris EN; White HD; Harrington RA; Bhatt DL;
    JACC Cardiovasc Interv; 2016 Sep; 9(18):1905-13. PubMed ID: 27659566
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of secondary prevention drug therapy in patients with acute coronary syndrome after hospital discharge.
    Lee HY; Cooke CE; Robertson TA
    J Manag Care Pharm; 2008 Apr; 14(3):271-80. PubMed ID: 18439049
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of Lipoprotein(a) as a Residual Risk Factor in Long-Term Cardiovascular Outcomes in Patients With Acute Coronary Syndrome Treated With Statins.
    Takahashi D; Wada H; Ogita M; Yasuda K; Nishio R; Takeuchi M; Shitara J; Tsuboi S; Dohi T; Suwa S; Miyauchi K; Daida H; Minamino T
    Am J Cardiol; 2022 Apr; 168():11-16. PubMed ID: 35067346
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Statins and Incidence of Contrast-Induced Acute Kidney Injury Following Coronary Angiography - Five Year Experience at a Tertiary Care Center.
    Sreenivasan J; Khan MS; Li H; Zhuo M; Patel A; Fugar S; Tarbutton M; Siddamsetti S; Yadav N
    Cardiovasc Revasc Med; 2019 Aug; 20(8):654-658. PubMed ID: 30318173
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reverse vessel remodeling but not coronary plaque regression could predict future cardiovascular events in ACS patients with intensive statin therapy--the extended JAPAN-ACS study.
    Miyauchi K; Daida H; Morimoto T; Hiro T; Kimura T; Nakagawa Y; Yamagishi M; Ozaki Y; Kadota K; Kimura K; Hirayama A; Kimura K; Hasegawa Y; Uchiyama S; Matsuzaki M;
    Circ J; 2012; 76(4):825-32. PubMed ID: 22451449
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.